360 related articles for article (PubMed ID: 6106367)
21. Molecular basis for hycanthone drug action in schistosome parasites.
Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
[TBL] [Abstract][Full Text] [Related]
22. "Control of schistosomiasis": morbidity-reduction and chemotherapy.
Mott KE
Acta Leiden; 1982; 49():101-111. PubMed ID: 7188153
[No Abstract] [Full Text] [Related]
23. Goals of applied chemotherapeutic research in schistosomiasis.
Davis A
Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):73-6, 190-4. PubMed ID: 7455513
[No Abstract] [Full Text] [Related]
24. [Therapeutic evaluation of oltipraz in human S. mansoni infection].
de Carvalho SA; Amato Neto V; Zeitune JM; Shikanai-Yasuda MA; Takiguti CK
Rev Inst Med Trop Sao Paulo; 1986; 28(4):271-7. PubMed ID: 3105039
[No Abstract] [Full Text] [Related]
25. Evaluation of schistosomicides against experimentally established Schistosoma mansoni infections in mice and hamsters.
Yarinsky A
J Toxicol Environ Health; 1975 Nov; 1(2):229-42. PubMed ID: 1206769
[TBL] [Abstract][Full Text] [Related]
26. New aspects of the chemothrapy of bilharziasis with Ambilhar (Niridazole).
Fontanilles F
Egypt J Bilharz; 1974; 1(1):29-34. PubMed ID: 4619884
[No Abstract] [Full Text] [Related]
27. The prophylactic and curative effect of oltipraz in experimental schistosomiasis mansoni in mice.
Aboul-Atta AM
J Egypt Soc Parasitol; 1990 Jun; 20(1):187-95. PubMed ID: 2110222
[TBL] [Abstract][Full Text] [Related]
28. Studies on the effect of Amoscanate on the immature stages of S. mansoni and S. haematobium worms in hamsters.
Khalil SB; Girgis NI; Mansour NS
J Egypt Soc Parasitol; 1986 Dec; 16(2):699-706. PubMed ID: 3097173
[No Abstract] [Full Text] [Related]
29. [Oltipraz in one-day treatment of Schistosoma haematobium bilharziasis (pharmacokinetic data, therapeutic effects)].
Piéron R; Lesobre B; Mafart Y; Meyniel D; Lancastre F; Renard A; Simon J; Grégoire J; Basset P
Rev Med Interne; 1981; 2(2):231-7. PubMed ID: 7256027
[No Abstract] [Full Text] [Related]
30. Study on the efficiency of five antibilharzial drugs judged by she direct and serodiagnostic methods.
Saíf El-Din S; Basmy K; Shoeb SM
Egypt J Bilharz; 1975; 2(1):95-110. PubMed ID: 1181175
[No Abstract] [Full Text] [Related]
31. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
[No Abstract] [Full Text] [Related]
32. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
Buchter V; Hess J; Gasser G; Keiser J
Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
[TBL] [Abstract][Full Text] [Related]
33. Oltipraz treatment in experimental schistosomiasis mansoni. II. Effect of high dose oral therapy on worm load and process of copulation in infected mice.
Aboul-Atta AM; Hassan ZA; el-Ahl SS
J Egypt Soc Parasitol; 1989 Dec; 19(2):427-36. PubMed ID: 2504822
[TBL] [Abstract][Full Text] [Related]
34. [Hypersensitivity in human schistosomiasis due to Schistosoma mansoni and Schistosoma haematobium. II. In vitro study of the lethal activity of patient sera for schistosomules of S. mansoni. Relation to hypersensitivity tests].
Capron A; Capron M; Camus D; Vernes A
Pathol Biol (Paris); 1973 Dec; 21(10):1079-84. PubMed ID: 4589580
[No Abstract] [Full Text] [Related]
35. Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium.
El Ridi R; Tallima H; Salah M; Aboueldahab M; Fahmy OM; Al-Halbosiy MF; Mahmoud SS
Int J Antimicrob Agents; 2012 Mar; 39(3):232-9. PubMed ID: 22240411
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
[TBL] [Abstract][Full Text] [Related]
37. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni.
Katz N; Rocha RS; Chaves A
Rev Inst Med Trop Sao Paulo; 1982; 24(1):40-8. PubMed ID: 6750759
[No Abstract] [Full Text] [Related]
38. Preliminary report on long term cure of schistosomiasis using metrifonate (Bilarcil/Dipterex)--a new antischistosomal drug.
Onadeko MO
West Afr J Pharmacol Drug Res; 1979; 5(1):19-24. PubMed ID: 122130
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of oltipraz and its oxy-analogue on the viability of Schistosoma mansoni and the activity of glutathione S-transferase.
Nare B; Smith JM; Prichard RK
Biochem Pharmacol; 1991 Aug; 42(6):1287-92. PubMed ID: 1888337
[TBL] [Abstract][Full Text] [Related]
40. Antischistosomal activity of S-2-[[2-(2-thiazolylcarbamoyl) ethyl] amino] ethyl hydrogen thiosulfate in vitro and in vivo.
Voigtman RE; Thompson PE
J Parasitol; 1977 Dec; 63(6):1053-9. PubMed ID: 412938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
